An automated reasoning framework for translational research  by Riva, Alberto et al.
Journal of Biomedical Informatics 43 (2010) 419–427Contents lists available at ScienceDirect
Journal of Biomedical Informatics
journal homepage: www.elsevier .com/locate /y jb inAn automated reasoning framework for translational research
Alberto Riva a,*,1, Angelo Nuzzo b,1, Mario Stefanelli c, Riccardo Bellazzi c
aDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL, USA
bCentre for Tissue Engineering, University of Pavia, Pavia, Italy
cDepartment of Computer Engineering and System Science, University of Pavia, Pavia, Italya r t i c l e i n f o
Article history:
Received 2 September 2009





Genome-Wide Association Studies1532-0464/$ - see front matter  2009 Elsevier Inc. A
doi:10.1016/j.jbi.2009.11.005
* Corresponding author.
E-mail address: ariva@uﬂ.edu (A. Riva).
1 These authors contributed equally to this work.a b s t r a c t
In this paper we propose a novel approach to the design and implementation of knowledge-based deci-
sion support systems for translational research, speciﬁcally tailored to the analysis and interpretation of
data from high-throughput experiments. Our approach is based on a general epistemological model of
the scientiﬁc discovery process that provides a well-founded framework for integrating experimental
data with preexisting knowledge and with automated inference tools.
In order to demonstrate the usefulness and power of the proposed framework, we present its applica-
tion to Genome-Wide Association Studies, and we use it to reproduce a portion of the initial analysis per-
formed on the well-known WTCCC dataset. Finally, we describe a computational system we are
developing, aimed at assisting translational research. The system, based on the proposed model, will
be able to automatically plan and perform knowledge discovery steps, to keep track of the inferences per-
formed, and to explain the obtained results.
 2009 Elsevier Inc. All rights reserved.1. Introduction
The rapid evolutionof high-throughput experimentalmethods in
the past decade has led to a revolution in the way biomedical re-
search is performed, opening theway to large-scale translational ap-
proaches. The exponential increase of the amount of data produced
by each experiment, at all levels (from next-generation DNA
sequencing to genotyping, to gene expression analysis, to proteo-
mics, to high-level observations on genotype/phenotype correla-
tions) and at a steadily decreasing cost, has opened up
unprecedented new opportunities for studying biological systems
ona large scale, takingaholistic perspective thatpromises to expand
our understanding of biological processes and of their connections
with clinically relevant ﬁndings. ‘‘In-silico” experiments, that are
becoming part of the standard process of knowledge discovery, con-
sist of a complex sequence of iterative data analysis steps, each of
which produces intermediate data and results that need to be prop-
erly stored and maintained. However, the availability of such high
volumes of data, combined with the need to access large amounts
of heterogeneous information available on the World-Wide Web,
posesmajor challenges in terms of datamanagement and data anal-
ysis. The need for improved computational environments oriented
to data and knowledge integration has been widely recognized. Re-
sources likeSRS [1] andNCBI’sEntrez [2]havebeenempoweredwithll rights reserved.sessions and query management capabilities; the adoption of Web
Services technologyhas allowed thecreationof complex, distributed
data analysis tools (e.g., Soaplab [3], BioMOBY[4,5] andBioMart [6]);
the application of workﬂowmanagement technology to biomedical
research has led to the implementation of IT platforms able to coor-
dinate interdependent analysis steps [7] (e.g., stand-alone tools like
Orange [8], the Taverna workbench [9,10], and client–server sys-
tems, like Pegasys [11] and BioWMS [12]).
In this paper we propose and discuss the application of KB-DSS
to the ﬁeld of translational bioinformatics. As recognized in a re-
cent seminal paper by Aniba et al. [13], the availability of techno-
logical solutions is not enough, in itself, to cope with the data
management and knowledge discovery challenges encountered in
current biomedical research. Drawing on past experiences in other
areas of biomedical informatics [14], we propose an architecture
for the implementation of knowledge-based decision support sys-
tems (KB-DSS) speciﬁcally tailored to translational research. Such
systems should be able to select and perform the data gathering,
analysis, and interpretation ‘‘actions” that would be the most
appropriate towards solving a given task, to automatically plan
and perform knowledge discovery steps, keeping track of the infer-
ences performed, and to explaining the obtained results. Moreover,
they should be able to formally represent and manage multiple
alternative hypotheses at the same time, and to use them for plan-
ning experiments, and to update them according to the experiment
results.
A recent example of a complete running system for automated
discovery in molecular biology is represented by the Robot
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able to generate hypotheses explaining the available evidence, to
plan experiments to test them, to run the experiments in a fully
automated laboratory, and to interpret their results, starting new
cycles if needed. The idea of an explicit, structured representation
of hypotheses has been explored in a recent work by Roos et al.
[16], but without a well-deﬁned reasoning framework to operate
on them. Past examples include a wide variety of medical expert
systems for diagnosis [17,18], therapy planning [19], patient mon-
itoring and critical care [20].
Although the basic principles are similar, the use of KB-DSS for
translational bioinformatics presents some signiﬁcant differences
compared to the above-described experiences. To start, while the
traditional use of KB-DSS is aimed at diagnostic and therapeutic
reasoning, in the translational bioinformatics ﬁeld the goal is, in-
stead, to support scientiﬁc discovery. Moreover, the classical archi-
tecture of a KB-DSS consists of an integrated knowledge base and a
general inference mechanism able to reason on the available data
and knowledge. In the context of translational bioinformatics, this
model needs to evolve to take into account both the very large
scale of the datasets being studied (while a traditional biomedical
expert system normally handles up to a few hundred variables at
most, high-throughput experimental techniques can sample mil-
lions of variables at once), and the availability of an extremely
large corpus of background knowledge, in essentially unstructured
form, in online repositories. As a consequence, we believe that in
order for a KB-DSS to be successful in this context, it should be
based on a conceptual framework designed to support the reason-
ing processes speciﬁc to translational research. In this scenario, the
goal is not to perform complete inferential and experimental cy-
cles, but to provide researchers with more efﬁcient tools to better
structure and organize the research process, and to more efﬁciently
perform its repetitive aspects. The conceptual model should there-
fore include meta-models of reasoning in scientiﬁc discovery, spe-
cialized to molecular medicine, and a powerful and general
information management architecture [13].
We address these requirements by proposing an automated
reasoning model that accurately describes the current practice of
scientiﬁc discovery in molecular medicine. The model can be used
to guide the development of KB-DSS for translational research, spe-
ciﬁcally tailored to the analysis and interpretation of data from
high-throughput experiments. Our approach is based on a general
epistemological model of scientiﬁc discovery process that provides
a well-founded framework for integrating experimental data with
preexisting knowledge and with automated inference tools. The
model, called Select and Test Model (ST-Model) [21,22], was ini-
tially developed in the ﬁeld of Artiﬁcial Intelligence in Medicine
to support the design and implementation of expert systems. We
will show that the ST-Model can be instantiated to guide the devel-
opment of KB-DSS for high-throughput biomedical research. We
will also describe a computational system we are developing,
which allows investigators to explicitly formulate and represent
hypotheses grounded in existing biomedical knowledge, to vali-
date them against the available experimental data, and to reﬁne
them in a structured, iterative process.
As a proof of concept we will focus, in particular, on Genome-
Wide Association Studies (GWAS), which aim at discovering rela-
tionships between one or more variables at the molecular level
and a phenotype. Case–control association studies attempt to ﬁnd
statistically signiﬁcant differences in the distribution of a set of
markers between a group of individuals showing a trait of interest
(the cases) and a group of individuals who do not exhibit the trait
(the controls). GWAS rely on large-scale genotyping techniques to
analyze a very large set of genetic markers, in order to achieve a
sufﬁciently good coverage of the entire genome, a strategy that is
appropriate when there is little or no a priori information aboutthe location of the genetic cause of the phenotype being studied.
Because of their increasing importance in the ﬁeld of molecular
medicine, of the constant advances in the technology they are
based on, and of the analytical challenges they pose, GWAS are
an ideal example to demonstrate the application of our proposed
approach.
This paper is structured as follows: Section 2 describes the ST-
Model in detail; Section 3 presents the application of the ST-Model
to GWAS, Section 4 is devoted to an overview of the design and
implementation of the computational system we are developing,
and Section 5 describes a case study in which the ST-Model is ap-
plied to a well-known GWAS. The paper ends with some conclu-
sions summarizing the methodology described in the article and
discussing its applicability to translational research.2. The ST-Model
Cognitive science research shows that experts engaged in a
problem-solving task typically perform a ﬁxed sequence of inferen-
tial steps that may be repeated cyclically. In our context, the task
consists in generating and evaluating new explanatory hypotheses,
starting from a deﬁnition of the research problem and a set of
available data. Following the well-known Generate-and-Test para-
digm [23], those steps are: (i) a hypotheses selection phase, in which
the initially available information is used to generate a set of can-
didate hypotheses and (ii) a hypotheses testing phase, in which
hypotheses selected in the previous step are used to predict ex-
pected consequences, that are then matched with available or
other (possibly new) information in order to conﬁrm or disprove
them.
As reported in [21], this can be described as a process of abduc-
tion, interpreted as an inference to the best explanation. Formally,
abduction is a method of logical inference introduced by Peirce
and Buchler [24], corresponding to the logical fallacy known as
‘‘afﬁrming the consequent”: if it is known that a implies b, and b
is observed to be true, then it can be assumed that a is true. Since
b may be true because of other causes, this inference may be
wrong. This kind of inference is defeasible and thus non-monotonic
(since its conclusions may be disproved by additional evidence),
and is at the basis of scientiﬁc discovery, theory revision, and both
selective and creative reasoning [21].
The ST (Select and Test) Model is a general framework for auto-
mated reasoning that formalizes the process of inference to the
best explanation as an iterative sequence of elementary inferential
steps. Each step in the model is implemented by a speciﬁc infer-
ence type, as shown in the schema in Fig. 1. The ﬁrst step of the
process is an abstraction, through which a set of high-level features
are extracted from the initial data and information. This is followed
by an abduction step, in which the abstracted features are used to
construct one or more hypotheses, each of which is a potential
explanation for the observed data. Indeed, part of the power of
the framework comes from its ability to handle multiple compet-
ing hypotheses at the same time. Hypotheses are then ranked to
deﬁne the order in which they will be examined in the following
steps, according to preference criteria which can be application-
dependent, or deﬁned on the basis of prior knowledge. The purpose
of ranking is to ensure that the ‘‘best” hypotheses are examined
ﬁrst, a heuristic strategy aimed at accelerating convergence to
the optimal solution. Next, a deduction step examines the best-
ranked hypotheses and derives a set of consequences that are ex-
pected to be true from each one. The deductive step will, in gen-
eral, make use of background domain knowledge. Predictions are
then matched against the available data, in the induction phase:
hypotheses whose consequences match the available data are re-
tained, while those that contradict the available data are discarded.
Fig. 1. The ST-Model.
A. Riva et al. / Journal of Biomedical Informatics 43 (2010) 419–427 421The process can then be repeated cyclically: existing hypothe-
ses can be reﬁned, or new ones generated, on the basis of addi-
tional data, the resulting set of hypotheses is re-ranked, and their
expected consequences are compared against the available exper-
imental data. The process terminates when no hypotheses are left,
or when a sufﬁciently small number of hypotheses is reached.
Although the ST-Model is a general epistemological model of
scientiﬁc reasoning, it can be directly translated into a set of con-
crete computational steps. We will illustrate this through a simple
example using propositional rules (representing implications of
the form ‘‘IF the antecedent is true, THEN the consequent is true”).
Let us imagine a knowledge base containing rules expressing the
relationship between transcription factors and the genes they reg-
ulate (see Table 1). Each rule expresses a know fact of the form: ‘‘If
transcription factor T is expressed, then gene G is upregulated.” Let
us also imagine we have performed a gene expression microarray
experiment, and that analysis of its results allows claiming that
genes G1 and G3 are up-regulated and that gene G2 is unchanged,
while no information is available on T1 and T2 (this is the outcome
of the abstraction step, in which ‘‘raw” numerical values are con-
verted into domain-speciﬁc assertions about the behavior of oneTable 1
Knowledge base of propositional rules.
1. T1 (transcription factor T1 is expressed)? G1 (gene G1 is up-regulated)
2. T1 (transcription factor T1 is expressed)? G2 (gene G2 is up-regulated)
3. T2 (transcription factor T2 is expressed)? G1 (gene G1 is up-regulated)
4. T2 (transcription factor T2 is expressed)? G3 (gene G3 is up-regulated)or more biological objects). Starting from the observation that gene
G1 is up-regulated, the abduction step uses rules 1 and 3 to gener-
ate the two alternative hypotheses ‘‘T1” and ‘‘T2”, since both of
them cause gene G1 to be up-regulated. The ranking step now or-
ders the hypotheses, for example on the basis of a certainty factor
associated with each rule. Let us imagine that according to the
ranking function used here, hypothesis ‘‘T1” should be tested be-
fore ‘‘T2”. The deductive step now uses rule 2 to derive the fact that
gene G2 should be up-regulated as an expected consequence of
hypothesis ‘‘T1”. The next step consists in verifying whether this
predicted consequence is actually conﬁrmed by the available data.
Since in this example gene G2 is not up-regulated, the eliminative
induction step will rule out hypothesis ‘‘T1”. Hypothesis ‘‘T2” is
tested next, and rule 4 produces the expected consequence that
gene G3 should be up-regulated. Since this is veriﬁed against the
experimental evidence, hypothesis ‘‘T2” is selected as the best
explanation for the available data.
In the following sections we show how the ST-Model can be
used as the basis for the implementation of KB-DSS in translational
bioinformatics, providing a sound way to organize complex work-
ﬂows and experiments (both in silico and in vitro), and grounding
the analysis process on a clear epistemological framework. We will
substantiate our claim by applying the ST-Model to the problem of
deﬁning a KB-DSS for supporting GWAS.3. The ST-Model for Genome-Wide Association Studies
The ultimate goal of GWAS is to unravel the molecular mecha-
nisms underlying complex phenotypic traits, by searching for sta-
tistically signiﬁcant differences in the distribution of a set of
genetic markers between a set of cases and one of controls. Since
GWAS normally assume little or no a priori knowledge about the
genetic cause of the trait under study, they need to essay a very
large set of genetic markers, in order to sample the entire genome
with a sufﬁciently high granularity.
Although the technology to perform GWAS has in recent years
seen dramatic improvements, thanks to the development of geno-
typing microarrays and deep sequencing, these studies still suffer
from limitations that reduce their ability to tackle complex dis-
eases [25]. In GWAS, as in all high-throughput molecular medicine
contexts, the number of genetic markers tested is much higher
than what can be analyzed manually. While the ability to sample
hundreds of thousands of variables in parallel provides great ben-
eﬁts in terms of throughput and experimental costs, it also makes
it harder to ensure that the results obtained are statistically signif-
icant. The number of available subjects is often too small to guar-
antee a statistical power sufﬁcient to detect small causal effects,
which are likely to be present in the case of complex genetic disor-
ders. Variables are treated as being independent of each other,
while it is well known that genetic factors are often correlated with
each other (for example, due to genetic linkage), and that the
majority of phenotypes are caused by the interplay of multiple ge-
netic factors. Finally, these studies provide limited explanation
capabilities: even when the analysis phase is able to identify one
or more genetic factors that are signiﬁcantly associated with the
phenotype, it does not necessarily provide an indication of the
mechanism through which they affect the phenotype, something
that instead has to be worked out a posteriori by the investigator.
A KB-DSS for GWAS would help properly design and perform
each inferential step, including formulating new hypotheses, com-
paring them with the existing evidence, and planning conﬁrmatory
experiments. The ST-Model described in the previous section
provides a foundation for automated reasoning and a meta-archi-
tecture for computational environments, since it represents a
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instantiation of the ST-Model for case–control GWAS.
A classical GWAS can be represented in the following way:
Abstraction: The ﬁrst step consists of selecting the clinical mea-
surements that are needed to properly deﬁne the phenotype, and an
initial set of individuals sharing the deﬁned phenotype. Phenotype
deﬁnition, data pre-processing, variable summarization, SNP selec-
tion, subpopulation handling, and correction for stratiﬁcation, may
all be viewed as part of the abstraction step, which allows moving
fromagenericdeﬁnitionof the study to a ‘‘computable” problem[26].
Abduction: Hypotheses are generated by testing the SNPs in the
available dataset for association with the phenotype. The analysis
tool used to perform the statistical association test produces a
set of candidate SNPs as result; each SNP in this set therefore rep-
resents an independent hypothesis, of the form ‘‘the alleles of SNP
x are signiﬁcantly associated with the phenotype”. This step in-
volves a creative abduction: at the start of the process, all SNPs
can potentially be associated with the phenotype, just by virtue
of being part of the genotyping dataset, but none of these associa-
tions is supported by evidence. Only after statistical analysis those
SNPs that are potential ‘‘good statistical explanations” for the phe-
notype are selected, and the hypothesis space is populated. This
creative step differs from the selective abduction performed in
diagnostic reasoning, where a set of already established hypothe-
ses is present in the knowledge base, and the data are only used
to select the ones that may be a good explanation of the data.
Ranking: Candidate SNPs are ordered according to their biologi-
cal or statistical signiﬁcance. For example, the ranking function
could be based on the p-valuesmeasuring the statistical signiﬁcance
of the association, or on the location of each SNP in the genome.
Deduction: Once the hypothesis space is populated, the validity
of each hypothesis (i.e., of the association of each individual SNP
with the phenotype) is assessed, relying on the biological knowl-
edge available on that SNP. In this phase, additional information
about each top-ranked candidate SNP is derived, with the goal of
establishing a biologically-founded relationship between SNPs
and the phenotype that may explain the observed statistical asso-
ciation. A common strategy is to identify genes located close to the
SNPs, and to study the metabolic pathways or GeneOntology clas-
ses they belong to, under the assumption that SNPs act as markers
for candidate genes. In the translational bioinformatics context,
this step can rely on the extremely extensive collections of bio-
medical information that are available in online repositories, in or-
der to identify possible consequences of the hypothesis under
consideration. Although the volume and depth of such information
is constantly increasing, it is in general formalized and represented
in different, possibly incompatible ways in different sources. More-
over, these information repositories are dynamic: their contents
may change often as a consequence of research advances, and
the results of the deductive step are therefore non-monotonic.
For this reason, it will be increasingly important to develop data
integration tools, able to provide a uniform, consistent, and dynam-
ically updated view of a collection of related data elements, possi-
bly coming from disparate sources.
Induction: If an over-representation of consequences matching
the phenotype is found, this provides evidence that the hypotheses
under consideration are correct; otherwise, the hypotheses just
tested are discarded. Eliminative induction allows reduction of
the hypothesis space by evaluating if any of the results of the
abduction step are ruled out by the currently available knowledge.
After the ﬁrst run of the model, a list of candidate SNPs is re-
tained. These SNPs can be then tested in conﬁrmatory studies, or
can be validated through meta-analysis, by running a new deduc-
tion/eliminative induction cycle. Alternatively, the researcher may
want to reﬁne the phenotype deﬁnition and repeat the entire anal-
ysis on a different set of subjects.Analysis at the SNP level is usually followed by analysis at the
gene level, whereby SNPs are treated as markers for the genes they
belong to (and that are assumed to be the real causal factors for
the phenotype). This suggests that the reasoning process involved
inmodernbiological research proceeds not just through cyclic tasks,
but also by changing the space in which hypotheses are formulated.
Let us consider again the problem of ﬁnding a relationship be-
tween the genotype and a disease phenotype. In general terms, this
problem is intractable since the overall hypotheses space is
extraordinarily large (every possible combination of all genetic fac-
tors) and for the most part unobservable. In practice, the hypothe-
sis space is reduced to the set of markers (e.g., SNPs) that current
technologies can sample; this allows abduction to be performed
as a ‘‘creative” step, searching through a ﬁnite space of potential
hypotheses, in which experiments are feasible and the problem
is, at least in theory, solvable. Alternatively, the abstraction step
can create new hypotheses involving genes rather than SNPs.
Again, this can be modeled through the ST-Model: the problem is
restated, becoming ‘‘are the genes containing the associated SNPs
related to the phenotype?”, and the reasoning process then pro-
ceeds at this higher level of abstraction. Gene expression analysis
or knock-out experiments can be used in the inductive phase to
conﬁrm or disprove the new hypotheses, now expressed in terms
of genes instead of SNPs. In the same way, individual genes can
be abstracted again into pathways or functional classes, leading
to another run of the ST-Model at an even higher level of abstrac-
tion (Fig. 3). This is indeed the process through which complex
experiments ﬁll the gap between the ‘‘punctual” analytical ap-
proach and the ‘‘global” solution of the overall problem being stud-
ied. This reasoning path reﬂects the requirement, necessary for the
proper interpretation of GWAS, to relate a statistically signiﬁcant
association with a causal, biological explanation.
While the large-scale model depicted in Fig. 3 is general enough
to represent the overall reasoning process and to guide the imple-
mentation of an actual computational system, this step is in gen-
eral quite complex, because of the need to integrate a variety of
different analytical methods speciﬁc for different domains and
the ability to manage different hypotheses spaces at the same time,
and is therefore outside the scope of this work. In this paper we
concentrate on the implementation of the portion of the model
that handles the selection of candidate SNPs, as described in
Fig. 2. The next section will describe the current state of this work,
and Section 5 will present its application to a case study.4. A computational infrastructure for Genome-Wide
Association Studies based on the ST-Model
We are developing a distributed, modular computational envi-
ronment, based on the ST-Model, to support the above described
style of research. The purpose of our system is to facilitate the anal-
ysis and interpretation of experimental results by automating the
most common data management and integration tasks, as well as
the required reasoning steps. In this section we brieﬂy describe
the system components and their role in the overall development
of the discovery process.
The main components of the system in its current version are:
1. The Phenotype Miner, a module for phenotypic data manage-
ment and inspection. We previously proposed the application
of data warehouse concepts to facilitate the investigation of
biomedical data by researchers lacking technical expertise and
database skills. The Phenotype Miner provides a simple and
effective tool to organize, represent and explore phenotypic
data along multiple dimensions, and to easily create sets of sub-
jects based on one or more phenotypes of interest [27,28].
Fig. 2. The ST-Model for abductive inference in GWAS studies.
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quality-control phase [29]. The GWAS assistant implements for-
mal methods, based on Multi-Criteria Decision Making theory,
for setting appropriate genotyping rate thresholds for GWAS.Fig. 3. A GWAS represented by multiple instances at3. Genephony, a knowledge management tool for genomic data-
sets, designed to support large scale, exploratory research at
the genome-wide level by assisting researchers in manipulating
and exploring large datasets of genomic information. Genepho-
ny offers researchers a set of integrated and automated tools to
easily create new datasets containing both experimental data
and background knowledge from public resources, to annotate
them and to export them in a variety of common formats
[30]. The main functionalities provided by the platform are:
the ability to easily deﬁne and handle very large, integrated
datasets of genomic information; a simple, consistent and
easy-to-use interface; and high interoperability with other
commonly used software tools, achieved through the use of
standard data exchange formats and communication protocols.
4. A high-levelmodule to support the analysis and interpretation of
results. This module, still under development, will provide
hypothesis generationandmanagement capabilities,will coordi-
nate the interactions between the system components, and will
facilitate access to biomedical data and knowledge repositories.
The components, which were initially developed as independent,
stand-alone systems, are now being integrated into a comprehen-
sive decision support system. While at the practical level integra-
tion is accomplished using Web Services protocols such as SOAP
[28], at the conceptual level the coordination and interplay
between these modules is guided by the ST-Model framework, as
described in the following paragraphs:
Abstraction. A ﬁrst, required step in the computational investi-
gation of the genetic bases of diseases is an accurate deﬁnition of
the phenotype under study. This is necessary to guide both the
selection of the subjects to be studied and the choice of the exper-
imental strategy to be followed (e.g., whether to perform a gen-
ome-wide scan or a more targeted analysis). The ﬁrst component
of the system, the Phenotype Miner, fulﬁlls these requirements
by providing a data collection infrastructure, a data warehouse sys-
tem for phenotypic data, and a tool to formally deﬁne the pheno-
types of interest. Phenotypes are deﬁned by specifying a set of
variables and the ranges of values they may take. Our systemthe ST-Model at different levels of abstraction.
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ical data satisfy the deﬁnition of the phenotype of interest, without
requiring the user to write database queries (that are instead auto-
matically generated by the system). Phenotypes are formalized as a
set of conditions in the form of attribute/value pairs, combined
using logical operators (AND, OR) to deﬁne more and more com-
plex phenotypes. In particular, the AND operator allows the spe-
cialization of a deﬁned phenotype, while the OR operator is used
to merge different phenotypes into a single more comprehensive
one. A graphical wizard facilitates the creation of the rules that de-
ﬁne a phenotype. Once these rules are deﬁned, they are stored in
the phenotype deﬁnition tables, and the SQL statement to select
the subgroup of individuals satisfying them is automatically gener-
ated. Once the genotypes for the selected subjects are retrieved,
the GWAS assistant can be used to perform the necessary quality
control and pre-processing steps, including setting the genotyping
rate and correcting for stratiﬁcation.
Abduction and ranking: Performing a ‘‘classical” SNP-based asso-
ciation study on all SNPs in the dataset (using an appropriate anal-
ysis program such as PLINK [31]), the high-level module identiﬁes
those that show the strongest statistical association with the phe-
notype, and uses them to populate the hypothesis space. Candidate
SNPs can then be ranked according to different criteria; for exam-
ple their p-value, or their functional and biological properties,
determined through the use of a large-scale annotation tool such
as Genephony.
Deduction: After selecting the set of genomic markers that are
thought to be related to the phenotype and generating a corre-
sponding set of hypotheses, the system exploits the data integra-
tion and manipulation features offered by Genephony to derive
their expected consequences. Using the annotation functions pro-
vided by Genephony, it is easy to determine, for example, the set
of genes that contain the SNPs found in the previous step. A
hypothesis based on SNPs can thus be transformed into a hypoth-
esis based on genes, on the assumption that SNPs may be used asFig. 4. A schematic representation of an analysis tasks that may be performed using the s
calls to Genephony.genetic markers for genes. The user may now work towards verify-
ing the gene-level hypotheses, or proceed to generate new hypoth-
eses at a different abstraction level, for example by retrieving the
pathways that the genes belong to, and analyzing all SNPs belong-
ing to the genes in the pathways.
Induction and hypothesis space maintenance: The high-level mod-
ulewill provide a ‘‘controller” interface bywhich the user can gener-
ate, test and select hypotheses according to the conceptual
framework described by the ST-Model. The controller communi-
cates with the other components of the system through appropriate
Web Services interfaces, and uses their functionalities to implement
the inferential steps that constitute the model. The controller will
also provide a function to rule out hypothesis that, after the deduc-
tion step, appear to be, irrelevant or trivial. Since the eliminative
induction step is strongly dependent on the users’ preferences, we
plan to leave this feature under their direct control.
The current version of the integrated module interface consists
of three main components (snapshots are shown in Fig. 4): (i) a
section for dataset uploading, (ii) a hypotheses workspace, dynam-
ically populated by the sets of hypotheses generated at each step of
the analysis, and (iii) a central interactive section, used both to dis-
play the contents of each hypothesis and to provide commands to
operate on it. Commands are customized on the basis of the
hypotheses contents, so that the possible next steps of the analysis
are automatically generated by the system, leaving to the user the
choice of which speciﬁc reasoning path to explore.
5. The ST-Model in Genome-Wide Association Studies: a case
study
In order to show that the ST-Model can be useful to model
molecular medicine research in general, and GWAS in particular,
here we apply it to the well-known Wellcome Trust Case–Control
Consortium (WTCCC) study, a large scale association study that
has collected and genotyped samples on 14,000 subjects, affectedystem. PM indicates the Phenotype Miner, while arrows labeled GP represent remote
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this section, we will detail each phase of this study using the con-
ceptual framework provided by the ST-Model.
Abstraction: As previously described, the initial phase of a GWAS
analysis consists in abstracting the raw data into a set of ‘‘usable”
problem variables. This requires a precise deﬁnition of the pheno-
type, and a thorough data collection and validation process. In the
WTCCC study, quality control analysis was performed on the over-
all data set (17,000 subjects and 3000 controls), leading to the
exclusion of approximately 8% of the available SNPs and of around
800 patients. The control groups, population structures and sub-
structures, and effects of geographical variation were also analyzed
to avoid confounders.
Abduction: The hypothesis space was generated by running a set
of statistical association tests. Both standard statistical analysis
(trend and genotype test) and Bayesian approaches (Bayes factor
calculation) were applied. The result is a collection of SNPs that
are determined to be signiﬁcantly associated with membership
in the case or control groups.
Ranking: It is interesting to note that different ranking strategies
were applied to the hypotheses. SNPs were initially ranked on the
basis of their p-values (or of their Bayes Factor), also taking the sta-
tistical power of the association tests into consideration. In a sec-
ond stage, a higher ranking was assigned to SNPs belonging to
clusters of correlated, statistically signiﬁcant SNPs.
Deduction/Induction: To start, other published studies were
searched to conﬁrm or rule out the hypotheses so far generated.
In particular, the ﬁrst search was aimed at determining whether
the top-ranked SNPs were already known to be associated with
the diseases under study. The following steps are described as fol-
lows in the WTCCC report: ‘‘. . . assessments on the basis of positional
candidacy carry considerable weight, and, as we show, these already
allow us, for selected diseases, to highlight pathways and mechanisms
of particular interest. Naturally, extensive re-sequencing and ﬁne-
mapping work, followed by functional studies will be required before
such inferences can be translated into robust statements about the
molecular and physiological mechanisms involved” [32]. In other
words, in this case the reasoning process proceeds by identifying
the potential functional implications of each candidate SNP, on
the basis of background knowledge retrieved from the available
repositories. The induction phase then uses evidence from the lit-
erature and the data available in knowledge bases to affect the
ranking of the hypotheses or even, when sufﬁcient knowledge is
available, to rule some of them out entirely.
To better exemplify the application of the ST-Model to the
WTCCC study, we focus here on the results obtained for Type 2 Dia-
betes Mellitus (T2D). We will concentrate in particular on the rank-
ing, deduction, and induction steps, which require knowledge-
based analysis (see Fig. 5).
The ﬁrst task in the analysis consisted in checking whether the
selected SNPs were related to three gene variants known to be dia-Fig. 5. The ranking/deduction/induction steps of GWAS as implemented in the
WTCCC study.betes-related: PPARG (Peroxisomal Proliferative Activated Recep-
tor Gamma; P12A102), KCNJ11 (the inwardly-rectifying Kir6.2
component of the pancreatic beta-cell KATP channel) and TCF7L2
(transcription factor 7-like 2). In this case, a cluster of SNPs related
to TCF7L2 gave the strongest association signal for T2D. The
hypothesis set was also found to contain SNPs in close proximity
with a SNP that had previously been shown to be highly associated
with diabetes, but that was not present on the microarray platform
used in the study. This shows how hypothesis ranking can be af-
fected by the available domain knowledge.
The analysis then proceeded by considering the remaining
highly associated SNPs, following a line of reasoning which in-
volves searching for clusters of associated SNPs, linking them with
genes, and analyzing their functional properties, role in pathways,
shared protein domains, etc. As reported in the previous section,
this perfectly corresponds to iterating the deduction and induction
phases by invoking full cycles of the ST-Model in which the
hypotheses are formulated at different abstraction levels (genes,
proteins, pathways, etc.). In order to provide a further example of
this, we carried out an additional analysis step following the ST-
Model framework. Given the discovery, resulting from the previous
stage, that SNPs in the TCF7L2 gene are signiﬁcantly associated
with the presence of Type 2 Diabetes, we wanted to generate
new hypotheses at the metabolic pathways level. TCF7L2 is known
to be a critical component of the Wnt signaling pathway, that has
recently been linked to Type 2 Diabetes [33,34], and therefore rep-
resents a plausible candidate for a new hypothesis. Once again, we
have performed an abstraction (generalizing from a single gene to
one of the pathways that contain it) followed by an abduction (for-
mulating the hypothesis that this pathway explains the available
phenotype). We then performed the deduction step, in which we
derive expected consequences from our hypothesis and check
them against the available data, to conﬁrm or disprove the hypoth-
esis. To this end, we generated a set of 659 representative SNPs,
using the annotation tools described in the previous section: after
generating the set of all SNPs belonging to the genes in the Wnt
signaling pathway, we extracted those for which genotype data
is available in the WTCCC study, and we further selected a ‘‘prior-
itized” subset, giving preference to non-synonymous coding SNPs
and to SNPs in promoter regions, and ensuring an equal number
of SNPs from each gene. Finally, we removed SNP ‘‘rs4506565”
from this set, since this is the SNP that was found to be signiﬁ-
cantly associated with T2D in the WTCCC study, and therefore rep-
resents a hypothesis that was already tested. We then assigned a
score to each individual in the T2D cohort, calculated on the basis
of his/her genotypes for all the SNPs in the set, and we performed
the same operation on the two control groups (NBS and 58C). By
applying the Wilcoxon test (p < 0.01) we found a signiﬁcant differ-
ence between the scores obtained on the T2D cohort and the scores
obtained in either one of the control groups. In other words, we
were able to prove the hypothesis that there is a relationship be-
tween Type 2 Diabetes and the Wnt signaling pathway using the
available genotype data, rediscovering a known ﬁnding through
the proposed automated reasoning framework. A similar result
was found for a similar-sized group of individuals in the T1D (Type
1 Diabetes) cohort, using the same set of SNPs, something that
could indicate that the involvement of the Wnt pathway is com-
mon to both types of diabetes. Table 2 summarizes the results of
this experiment.
Note that the purpose of this experiment was to test whether
the system would be able to reproduce an already known result,
starting from a hypothesis (deduction step). We have not yet vali-
dated the overall induction/deduction mechanism, but we assume
that its errors (false positives, false negatives) will be determined
by the properties and performance of the algorithm applied in each
separate step (for example, relying on association study p-values in
Table 2
Results of the comparison between two diabetes datasets (T2D and T1D) and two








Each dataset contains genotype data for 659 SNPs in 1400 subjects. Each subject
received a score based on his/her genotypes, and the numbers in the third column
indicate the signiﬁcance of the difference of the average score for subjects in the
two compared groups. Numbers in bold represent differences that are signiﬁcant at
the 0.01 level.
426 A. Riva et al. / Journal of Biomedical Informatics 43 (2010) 419–427the induction phase). To ‘‘globally” assess the performance of our
system we would need to perform a study involving real users
(data analysts/biologists/physicians), something that is outside
the scope of this paper.
6. Discussion and conclusions
In this paper we have shown how the ST-Model, an epistemo-
logical model of the knowledge discovery process, can be used to
formally describe the reasoning processes performed by research-
ers in the context of high-throughput molecular research in gen-
eral, and of GWAS in particular. Our main claims are that the ST-
Model is able to describe the reasoning processes underlying cur-
rent practice in large-scale molecular medicine studies, and that
this model is amenable to be turned into a general computational
architecture for decision support in translational bioinformatics.
The ﬁrst claim is supported by the observation that creative
abduction, as reported by Magnani [21] and Peirce and Buchler
[24], is the fundamental step in the inference to the best explana-
tion. In this approach, the hypothesis space is dynamically created,
starting from a phenotype of interest, and progressively reﬁned on
the basis of the available knowledge, through a series of deduction/
induction cycles, possibly at different abstraction levels, and/or
through additional experiments.
The second claim directly addresses the usefulness of the ST-
Model for translational bioinformatics. The availability of large-
scale datasets generated by high-throughput methods and of easily
accessible repositories of background knowledge makes it now
possible to combine the advantages of hypothesis-free research
with those of hypothesis-driven research. We believe that a clear,
formal deﬁnition of the conceptual steps that compose the discov-
ery process can greatly beneﬁt the design of computational sys-
tems supporting high-throughput research, thus moving beyond
the typical ‘‘pipeline” model in which successive analysis steps
are concatenated in a ﬁxed, uni-directional sequence. A system
based on the ST-Model explicitly distinguishes the hypothesis def-
inition, hypothesis ranking, and hypothesis validation phases, and
organizes them in a cyclical exploratory process. Moreover, access
to the literature, to databases and to knowledge bases can be made
‘‘intentional”, i.e., the activity can be recorded as part of the inten-
tion of the user to ﬁnd a particular type of evidence which may
conﬁrm or rule out a hypothesis.
We therefore believe that the ST-Model can be used as a well-
founded framework to design Knowledge-Based Decision Support
Systems, able to perform complete reasoning cycles, going through
the abstraction, abduction, ranking, deduction, and induction steps
as necessary, and keeping track of the inferences performed and of
the intermediate hypotheses generated. Our experience shows that
it is feasible and practical to build computational systems, such as
the one we are developing, based on the ST-Model. However, it isimportant to remark that, although the ST-Model is an effective ap-
proach for descriptive and computational purposes, it is not neces-
sarily the best possible choice for all different applications. Its
purpose is to provide a general schema that ﬁts the most common
patterns of scientiﬁc discovery, but we recognize that there will al-
ways be cases that are not appropriately captured by this model.
Turning the steps of the conceptual model into actual software
tools requires a signiﬁcant design and implementation effort, and
in this respect our work is still in its preliminary stage. Although
the epistemological model we described lends itself well to the
development of ‘‘plug-and-play” software architectures, in which
each different component implements a speciﬁc reasoning task
independently of the rest of the system, our goal at this stage is
to provide researchers with a tool to effectively support their dis-
covery process, rather than a fully-automated system. We envision
that this experience will allow us to use the ST-Model as a design
principle to build a new generation of KB-DSS for translational re-
search in medicine, able to effectively integrate existing knowledge
and experimental data in an architecture for automated discovery.
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